These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17950881)

  • 1. Cancer clinical trials: development and implementation.
    Vail DM
    Vet Clin North Am Small Anim Pract; 2007 Nov; 37(6):1033-57; v. PubMed ID: 17950881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of toxicity in cooperative oncology clinical trials: the long and short of it.
    Gwede CK; Johnson DJ; Daniels SS; Trotti A
    J Oncol Manag; 2002; 11(2):15-21. PubMed ID: 11989815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking clinical trials for cytostatic drugs.
    Millar AW; Lynch KP
    Nat Rev Cancer; 2003 Jul; 3(7):540-5. PubMed ID: 12835674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of clinical trials in veterinary oncology.
    Burton J; Khanna C
    Vet Clin North Am Small Anim Pract; 2014 Sep; 44(5):977-87. PubMed ID: 25174911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Veterinary oncology clinical trials: design and implementation.
    Thamm DH; Vail DM
    Vet J; 2015 Aug; 205(2):226-32. PubMed ID: 25582798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of novel agents for the treatment of colorectal cancer: a critical review of current practice and some suggestions for the future.
    Marshall JL; Gehan EA
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):167-72. PubMed ID: 17519876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of phase II trial designs used in studies of molecular targeted agents: outcomes and predictors of success in phase III.
    El-Maraghi RH; Eisenhauer EA
    J Clin Oncol; 2008 Mar; 26(8):1346-54. PubMed ID: 18285606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Commentary on "European collaboration in trials of new agents for children with cancer" by Ablett et al.
    Smith MA; Anderson BD
    Eur J Cancer; 2004 Aug; 40(12):1893-5. PubMed ID: 15288292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response assessment in clinical trials: implications for sarcoma clinical trial design.
    Jaffe CC
    Oncologist; 2008; 13 Suppl 2():14-8. PubMed ID: 18434633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Gynecologic Oncology Group's role in the treatment of recurrent cervix cancer: current clinical trials.
    Coleman RL;
    Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S77-80. PubMed ID: 18584855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The convergence of cancer prevention and therapy in early-phase clinical drug development.
    Abbruzzese JL; Lippman SM
    Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trials in journal of clinical oncology.
    Cannistra SA
    J Clin Oncol; 2009 Jul; 27(19):3073-6. PubMed ID: 19451415
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase 0 clinical trials in oncology: a paradigm shift for early drug development?
    Takimoto CH
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):703-9. PubMed ID: 18615251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The creation of the Comparative Oncology Trials Consortium Pharmacodynamic Core: Infrastructure for a virtual laboratory.
    Paoloni M; Lana S; Thamm D; Mazcko C; Withrow S
    Vet J; 2010 Jul; 185(1):88-9. PubMed ID: 20621714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent progress of clinical trials in urologic oncology].
    Hinotsu S
    Gan To Kagaku Ryoho; 2006 Feb; 33(2):188-92. PubMed ID: 16484854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-arm clinical trials of new agents: some design considerations.
    Freidlin B; Korn EL; Gray R; Martin A
    Clin Cancer Res; 2008 Jul; 14(14):4368-71. PubMed ID: 18628449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Principle and practice of clinical phase III studies].
    Morant R
    Onkologie; 2008; 31 Suppl 2():53-7. PubMed ID: 18487870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update in methodology and conduct of cancer clinical trials.
    Therasse P; Eisenhauer EA; Buyse M
    Eur J Cancer; 2006 Jul; 42(10):1322-30. PubMed ID: 16737813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.